Latest

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

A recent study examined whether nebulized glycopyrrolate is safe to use in patients with severe COPD and comorbid cardiovascular risk factors.

COPD: Concurrent Nebulized Glycopyrrolate, Long-Acting Bronchodilators Safe

COPD: Concurrent Nebulized Glycopyrrolate, Long-Acting Bronchodilators Safe

The safety of concurrently administering nebulized glycopyrrolate with long-acting beta agonists was examined in 3 studies.

Improving Lung Function in Heterogenous Emphysema: Endobronchial Valves vs Standard of Care

Improving Lung Function in Heterogenous Emphysema: Endobronchial Valves vs Standard of Care

Forced expiratory volume in 1 second and length of hospital stay were assess to determine the benefit of endobronchial valve placement vs standard of care in emphysema.

Expert Panel Updates Recommendations for Endoscopic Lung Volume Reduction for Emphysema

Expert Panel Updates Recommendations for Endoscopic Lung Volume Reduction for Emphysema

Advanced emphysema may benefit from endoscopic lung reduction treatment.

ACEi, ARB Use Improves Pulmonary Function in Emphysema

ACEi, ARB Use Improves Pulmonary Function in Emphysema

Higher doses were independently linked to slower change in emphysema, especially among former smokers

ACE Inhibitors, ARBs Slow Progression of Emphysema

ACE Inhibitors, ARBs Slow Progression of Emphysema

Treatment with full-dose angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers was found to slow disease progression in patients with emphysema.

Utibron Neohaler Available for Maintenance Treatment of COPD

Utibron Neohaler Available for Maintenance Treatment of COPD

Sunovion announces Utibron Neohaler, an inhalation powder for the long term maintenance treatment of airflow obstruction in COPD patients.

Sign Up for Free e-newsletters